North America to Account for Major Revenue in Global Magnetic Resonance Imaging Market

The magnetic resonance imaging (MRI) technique is widely used for a detailed, non-invasive diagnostic imaging of various parts of the body, such as bones and joint, spinal cord, heart and blood cells, breast, prostate and adrenal glands. The modality is increasingly preferred for a detailed examination of brain tissues and various internal organs such as adrenal and prostate glands. The growing incidence of a variety of conditions related to central nervous system, spine lesions, tumors, and strokes is a key factor propelling the demand for MRI technique. In a number of developing and developed regions, healthcare clinics and hospitals are focusing on using better imaging contrast agents and employing a combinations of different sequence types for boosting their adoption among patient populations.

The global magnetic resonance imaging market is projected to rise from a valuation of US$6,611.0 Mn in 2017 to reach US$9,120.8 Mn by end of 2022. The market is forecast to expand at a CAGR of 6.6% from 2017 to 2022.

Get Report Sample @

An in-depth assessment of key aspects and factors influencing the growth of the magnetic resonance imaging market can be found below:

The substantial demand for noninvasive diagnostic imaging technique for a detailed anatomical study of almost any body part, particularly for soft tissues, is the primary factor driving the magnetic resonance imaging market. The wide popularity of MRI for the diagnosis of various neurological conditions in the absence of any standard alternate modality world over is a key factor boosting the market. A rising geriatric population and the growing prevalence of chronic conditions are crucial factors expected to catalyze the demand for MRI modality. Furthermore, the growing application of MRI-guided radiotherapy for brain tumors and in neurosurgical planning is a crucial factor accentuating the market.

Recent advances in scanning technology used in MRI and substantial advancements made in imaging contrast agents with respect to biologic tolerance and contrast capability are key developments expected to accentuate the market. In addition, the notable flexibility in the use of these agents is also a significant factor bolstering their demand among patient populations. For instance, paramagnetic contrast agent is preferred for obtaining an accurate and precise diagnosis. The rise of novel applications areas of MRI modality such as in diagnosing multiple sclerosis and breast cancer is a notable trend boosting the market.

The high cost of MRI system, along with problems in serviceability, and the low reimbursement Rates for MRI procedures in various developing countries are key aspects likely to hinder the growth of the market. Nevertheless, the advent of cardiac pacemaker-compatible MRI modality is a significant product innovation opening up exciting opportunities for market players.

Geographically, North America is the leading market and is predicted to hold the major revenue share throughout the forecast period. The revenue contributed by this regional market is estimated at US$3,212.1 Mn by 2022 end. The dominance is attributed to the vast commercial demand for technologically advanced MRI modality, mainly for a timely diagnosis of various chronic disorders among populations. Of all the product types of magnetic resonance imaging, 1.5 T MRI currently is the dominant segment and is predicted to hold a share of 49.5% by the end of assessment period.

Competitive Dynamics

A number of players are focused on launching of a wide portfolio of advanced MRI equipment and are focusing on geographic expansion in a move to consolidate their shares over the forecast period. Key players operating in the global magnetic resonance imaging market include Siemens Healthineers, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, GE Healthcare, Esaote SpA, Hitachi Medical Systems, Neusoft Corporation, and Xingaoyi.

View Report @

Advances in Magnetic Resonance Imaging Propelled by Healthcare Outlay

San Francisco, California, August 23, 2017 : The global advances in magnetic resonance imaging (MRI) market is foreseen to profit from elevating healthcare expenditure directed toward more research and development facilities. In a report by TMR Research, titled “Advances in Magnetic Resonance Imaging (MRI) Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” industry players are expected to gain momentum from the greater acceptance of modern MRI systems over conventional medical imaging modalities. As a result, there could be more chances of research and development efforts receiving support in the long run.

The adoption rate of MRI systems is prophesied to rise significantly in the coming years due to the growing incidences of oncological, neurological, and cardiac diseases. This could increasingly benefit the growth of the world advances in MRI market as private hospitals top the demand for MRI equipment in the near future. However, the serious shortage of liquid helium employed for decreasing the temperature of superconducting magnets used in MRI systems is anticipated to obstruct the growth of the market. Furthermore, the likely increase in hospital-grade helium prices could frustrate the demand for advances in MRI.

Nevertheless, MRI technology is projected to experience a telling push in its evolution owing to a profound interest exhibited by technology developers and manufacturers. Consequently, the demand is predicted to make a comeback in the world advances in MRI market. Developers and manufacturers could be looking to keep pace with bettering standards pertaining to positive recordkeeping and patient satisfaction. In this regard, they are forecasted to improve the demand for advances in MRI while working toward making MRI technology more patient-friendly.

If key geographies are concerned, the international advances in MRI market could witness the dominance of developed regions such as Europe and North America. The previous region could follow the latter securing a probable leading share in the market. With a view to improve diagnostics catered to their rising geriatric population, both these regions could supplement the growth of the international market while adopting continuous and aggressive technological developments in the field. On the other hand, Asia Pacific is envisaged to take a different route for progressing in the market. The developing region could exploit the rising demand in its market for posting an exponential CAGR during the forecast period 2017–2025.

Some of the important companies envisioned to make an impressive advancement in the worldwide advances in MRI market could be Esaote S.p.A, Bruker Biospin GmbH, Bayer Healthcare Pharmaceuticals, Advanced Imaging Research, Inc., and Agilent Technologies, Inc. More clarity on the competitive landscape of the market is expected to be provided in the publication.

Click on the link below to request a sample copy of the report